-
State Food and Drug Administration: 47 innovative drugs will be reviewed and approved in 2021
Time of Update: 2022-08-15
PXDaCh The State Food and Drug Administration released the "2021 Annual Drug Evaluation Report" on June 1 .
PXDaCh The State Food and Drug Administration released the "2021 Annual Drug Evaluation Report" on June 1 .
-
The New Deal is here, and the biopharmaceutical equipment industry is welcome!
Time of Update: 2022-08-15
"Enhancing the supply chain security level of high-end biopharmaceutical products and equipment" has been written into the "14th Five-Year Plan for Bioeconomic Development".
"Enhancing the supply chain security level of high-end biopharmaceutical products and equipment" has been written into the "14th Five-Year Plan for Bioeconomic Development".
-
High-tech regular bacteria Yieryou has a new action! Liquid probiotics are about to shock the market
Time of Update: 2022-08-15
At that time, Zhongweiyuan Biotechnology will Yieryou active probiotic drink was released It is understood that on May 18, the 2022 China Probiotics Industry Development Summit Forum, hosted by the People's Government of Longzihu District, Bengbu, Anhui, and the China Health Care Association, and co-organized by Zhongweiyuan Biotechnology, will be held at the Bengbu Radio and Television Station, Anhui Province.
-
Aiming at the broad domestic pharmaceutical equipment market, the construction of new projects for pharmaceutical machine companies is in full swing
Time of Update: 2022-08-15
. Taking Chutian Technology as an example, it announced on August 2 that the company intends to jointly fund the establishment of a company in Ningxiang City, Changsha, Hunan Province to provide medical equipment, medical equipment, mechanical engineering and other related industries with a team of experts in the precision manufacturing industry.
-
The national centralized procurement has saved a total of 300 billion!
Time of Update: 2022-08-15
On July 22, the National Health and Health Commission held a press conference. The responsible comrades of the National Health and Health Commission, the National Development and Reform Commission, t
-
Local innovative pharmaceutical companies are strengthening their "self-hematopoietic" capabilities, and another pharmaceutical company has reached a license out transaction
Time of Update: 2022-08-15
Judging from the license-out projects of domestic innovative drugs exceeding US$1 billion in recent years, for example, in early 2021, BeiGene announced that it had reached a cooperation and licensing agreement with Novartis on the development, production and commercialization of tislelizumab in multiple countries.
-
It is not easy for domestic new drugs to go overseas, this pharmaceutical company initiated another breakthrough!
Time of Update: 2022-08-15
It is not easy for domestic new drugs to go overseas In March this year, Innovent announced that the “going overseas” had failed, and the marketing application of its core product sintilimab was not approved by the US FDA .
-
The eve of bid opening!
Time of Update: 2022-08-15
The criteria for determining the companies to be selected in this centralized procurement continue the previous principle of price reduction (see Scenario 1 below), but the specific rules are more detailed (see Scenario 2 below) .
-
The State Food and Drug Administration took multiple measures to encourage innovation, and the review and approval of children's drugs continued to maintain a growth momentum
Time of Update: 2022-08-15
At present, the "Regulations on the Implementation of the Drug Administration Law of the People's Republic of China (Draft for Comments)" organized by the State Food and Drug Administration is being
-
Financing in the field of innovative drugs is active, and it has become a general trend for pharmaceutical companies to accelerate the development of new drugs
Time of Update: 2022-08-15
Since the beginning of this year, the pharmaceutical industry has been setting off a wave of financing; for example, recently, a number of pharmaceutical companies have announced that they will raise or have completed hundreds of millions of financing, which will be used for new drug research and development .
-
Chain pharmacies are about to enter the "10,000-store era", and the "big eats" and "big eats" mergers and acquisitions are accelerating
Time of Update: 2022-08-15
have basically completed the online channel layout At present, leading chain pharmacies including Yixintang, Common People, Yifeng Pharmacy, Dashenlin, Jianzhijia, Shuyu Civilian, etc.
-
Over 500 domestic drugs have been approved, and these two drugs account for the majority
Time of Update: 2022-08-15
. It is worth noting that obtaining new approvals for pharmaceutical companies can improve market competitiveness.
Therefore, many companies are currently accelerating the acquisition of new approvals through various forms It is worth noting that obtaining new approvals for pharmaceutical companies can improve market competitiveness.
-
Starting this month, more than 300 traditional Chinese medicine formula granules will be included in medical insurance
Time of Update: 2022-08-15
Dynamic adjustment In the next step, the Anhui Provincial Medical Insurance Bureau will also work with the Provincial Department of Human Resources and Social Security and the Provincial Drug Administration in accordance with the national standards for traditional Chinese medicine formula granules and the release of Anhui provincial standards, combined with clinical actual use and other factors, to implement the traditional Chinese medicine formula granules included in the fund payment scope.
-
There are 12 self-paid medicines in the collection of 18 varieties!
Time of Update: 2022-08-15
. It is worth mentioning that both diosmin and compound α-ketoacid are clearly required for oral normal-release dosage forms in the bulk purchase of eight provinces and two districts, but the current problem is that these two varieties of tablets The medicine belongs to the national medical insurance, while the capsule belongs to the non-medical insurance .
-
The consistency evaluation of 513 varieties of generic drugs has passed the review, and since July, there have been many products from pharmaceutical companies.
Time of Update: 2022-08-15
. Recently, Yuan Lin, director of the Drug Supervision Department of the State Food and Drug Administration, introduced that as of now, the State Food and Drug Administration has reviewed and approved 513 varieties of generic drug consistency evaluation applications involving 2,555 product specifications, and the quality of the listed generic drugs has been continuously improved.
-
Roche, Johnson & Johnson and many other multinational pharmaceutical companies announced their 2022 semi-annual financial reports. How about the "transcript"?
Time of Update: 2022-08-15
3%; consumption According to the sales data in the first half of the year, the revenue of the pharmaceutical business was US$26.
According to the data, Novartis’ net sales revenue in the first half of the year reached US$25.
-
The Center for Drug Evaluation of the State Food and Drug Administration released the "Annual Report on the Progress of New Drug Registration Clinical Trials in China (2021)"
Time of Update: 2022-08-15
pdf In order to fully grasp the progress of clinical trials for new drug registration in China, use information technology to improve drug supervision capabilities, disclose clinical trial progress information in a timely manner, and provide reference for new drug research and development, resource allocation, and drug review and approval, the Center for Drug Evaluation is based on the registration and approval of drug clinical trials.
-
Antibody research and development change?
Time of Update: 2022-08-15
Big Molecule Popular Tracks Platform differentiation stimulates potential Whether it is from the technical iteration path of overseas pharmaceutical companies or the development process of domestic macromolecular drugs in China, the most common summary of antibody drug research and development is undoubtedly "monoantibodies look at the target, non-mabone look at the platform", which is also highly summarized The important value of the innovative technology platform in the upgrading of antibody R&D technology .
-
Announcement on the Draft Standard of Nitrogen and Calcium Carbonate Pharmaceutical Excipients
Time of Update: 2022-08-15
pdf The State Pharmacopoeia Committee plans to formulate standards for pharmaceutical excipients of nitrogen and calcium carbonate.
pdf The State Pharmacopoeia Committee plans to formulate standards for pharmaceutical excipients of nitrogen and calcium carbonate.
-
The Chinese herbal medicine industry is accelerating its development towards standardization and standardization, and a large number of pharmaceutical companies will usher in good news
Time of Update: 2022-08-15
Driven by national policies, various localities are paying more and more attention to the development of the Chinese herbal medicine industry, and they have begun to accelerate the release of development plans and measures related to the cultivation and processing of Chinese herbal medicines to promote the standardized and large-scale cultivation of Chinese herbal medicines and improve the quality of Chinese herbal medicines .
